Latest in News & Research
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema
Authors suggest limiting duration of oral corticosteroid treatment to 90 days or less to reduce risk of adverse effects
Do Surgical Margins Affect the Risk of Recurrence in Cutaneous SCCs of the Scalp?
Risk of recurrence up for tumors that present concurrent invasion of the galea aponeurotica and close deep margins
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adult
Hispanic and non-Hispanic Black sexual minority males and females have higher rates of skin cancer than their heterosexual counterparts
Air Pollution Exposure Tied to New Psoriasis
Increase in psoriasis risk also seen among those with higher genetic vulnerability and increased exposure to air pollutants
Subsequent Skin Cancer Risk Increased for Stem Cell Transplant Recipients
Risk factors for skin cancer include chronic graft-versus-host-disease, male gender, voriconazole exposure
Cendakimab Effective for Moderate-to-Severe Atopic Dermatitis
Significant reduction seen in primary end point of mean percentage change in EASI score from baseline to week 16 with 720 mg once weekly
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
Significantly reduced rate of acne and rosacea seen in patients treated with CGRPi mAbs versus triptans, topiramate
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections
Four of the cases, identified in Tennessee, received counterfeit botulinum neurotoxin, administered by unlicensed individual
FDA Approves Zoryve for Atopic Dermatitis
The once-daily, nonsteroidal cream is approved for adults and children 6 years and older
Distinct Recurrence Patterns Seen for Primary, Relapsed Cutaneous Melanoma
Significantly lower progression-free survival, reduced distant metastasis-free survival seen for BRAF-mutated CM with immune checkpoint inhibitor
Sustained Safety, Efficacy Seen for Dupilumab in Atopic Dermatitis
Sustained benefit seen for adults with moderate-to-severe AD during five-year open-label extension study
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in Acne
Reduction seen in inflammatory and noninflammatory lesions, improvement seen in overall quality of life with EPA/DHA
Comprehending Compensation: A Dermatologist’s Definitive Guide to Navigating Job Offers, Pay Structure, Benefits & More!
As a dermatologist, your journey through medical school and residency has equipped you with the expertise to diagnose and treat more than 3,000 skin,...
Rural Residents Continue to Have Higher Odds of Skin Cancer
Rural-urban differences magnified by lower income and race
Satisfaction With Hair Growth Seen With Ritlecitinib in Alopecia Areata
Proportion of patients allocated to ritlecitinib who were satisfied increased or was maintained at week 48
Rules-Based Triage System Improves Patient Stratification for Skin Cancer
Three high-risk lesion groups seen faster in the new triage pathway, with a mean reduction of 26 days
Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
Increasing joint pain intensity associated with overall fatigue in patients with psoriasis with or without psoriatic arthritis
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
Recurrence developed in more patients who did not receive additional treatment and in fewer receiving nonsurgical treatments
RVUs vs. Collections in Dermatology: Understanding Productivity and Revenue Metrics for Dermatologists
Understanding RVUs (Relative Value Units) and collections is crucial for dermatologists as these metrics play a significant role in how your compensation and productivity...
Study Identifies Prognostic Factors for Localized Adnexal Carcinomas
Radiotherapy only associated with longer progression-free survival in patients with unresectable locally advanced or metastatic tumors
Low Recurrence Seen for Excision of Melanoma in Situ With 5-mm Margin
99.1 percent of the 351 MISs identified from 292 patients did not have clinical recurrence after excision
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
Decrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patients
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAFV600E mutation
24 of 1200